For much of the past two years, America has been first in line for COVID-19 vaccines and treatments. Now, as drugmakers develop the next generation of therapies, the White House is warning that if …
WASHINGTON — For much of the past two years, America has been first in line for COVID-19 vaccines and treatments. Now, as drugmakers develop the next generation of therapies, the White House is warning that if Congress doesn’t act urgently the U.S. will have to take a number.
Months ago, the White House began warning that the country had spent through the money in the $1.9 trillion American Rescue Plan that was dedicated directly to COVID-19 response. It requested an additional $22.5 billion for what it called “urgent” needs in both the U.S. and abroad. Paxlovid, when administered within five days of symptoms appearing, has been proven to bring about a 90% reduction in hospitalizations and deaths among patients most likely to get severe disease. Some 314 Americans are now dying each day from the coronavirus, down from more than 2,600 during the height of the omicron wave earlier this year.
“We know companies are working on additional, promising life-saving treatments that could protect the American people, and without additional funding from Congress, we risk losing out on accessing these treatments, as well as tests and vaccines, while other countries get in front of us in line,” said White House spokesman Kevin Munoz.
Administration officials declined to discuss specific treatments they are stymied from ordering because of contracting requirements. The Biden administration has said that while the U.S. has enough vaccine doses for children under 5, once they are approved by regulators, and for fourth shots for high-risk people over 50, it doesn’t have the money to order the new generation of doses.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
White House working to make Pfizer's Covid-19 antiviral pill more 'widely available'The Biden administration is set to unveil new details and announcements Monday on Paxlovid, Pfizer's antiviral Covid-19 pill, a White House official tells CNN.
Weiterlesen »
White House urges more funding for COVID treatmentsThe Senate last month closed in on smaller $10 billion package focused on domestic needs. But even that deal fell apart as lawmakers objected to an announcement from the Centers for Disease Control…
Weiterlesen »
White House: Without funding US will lose COVID treatmentsAfter two years at the front of the line for COVID-19 vaccines and treatments, the U.S. could soon have to begin taking a number.
Weiterlesen »
Dr. Birx publishes book on tackling COVID pandemic inside Trump's White HouseShe described her response to the moment Trump raised the possibility of injecting disinfectant into people to treat COVID-19.
Weiterlesen »
White House says without needed funding, US will lose COVID-19 treatmentsSenate Republicans are demanding that as part of a deal with Democrats, that side must agree to extend pandemic-related, Trump-era border restrictions.
Weiterlesen »
Dr. Birx publishes book on tackling COVID pandemic inside Trump's White HouseShe described her response to the moment Trump raised the possibility of injecting disinfectant into people to treat COVID-19.
Weiterlesen »